K

Cardiac Dimensions logo

Cardiac Dimensions

Healthcare & Life Sciences

Recent Finacing

Series E

Recent Raise

$53M


Cardiac Dimensions develops and commercializes the Carillon Mitral Contour System, a minimally invasive device for treating functional mitral regurgitation in heart failure patients.

Total Funding

$214.8M

Headquarters

Kirkland, USA

Founded

2001

Focus Areas

Minimally invasive
cardiovascular
mitral regurgitation
heart failure
medical device
global commercialization.

Investors

Ally Bridge Group logo
Lumira Ventures logo
Hostplus logo
Claret Capital Partners logo
Horizon 3 Healthcare logo
M.H. Carnegie logo